Figure 3.
The impact of CMV reactivation on NRM among the patients in each refined group by a landmark analysis at day 100. (A) Group 1. (B) Group 2.

The impact of CMV reactivation on NRM among the patients in each refined group by a landmark analysis at day 100. (A) Group 1. (B) Group 2.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal